For the treatment of febrile episodes in granulocytopenic cancer patients, a combination of bactericidal and intravenously administered broad spectrum agents is recommended. An aminoglycoside plus a beta-lactame (piperacillin, azlocillin or IIIrd generation cephalosporins) are the drugs of first choice in an empiric approach. Because of frequent parenteral interventions (e.g. catheters, cannulations) in thrombopenic patients with multifactorial immunosuppression, we consider the application of once daily drugs, such as ceftriaxone, netilmicin or amikacin. For single dose treatment (1st day two applications), we used ceftriaxone in combination with netilmicin or amikacin as the first approach and retrospectively evaluated 47 patients for efficacy and safety.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000238944DOI Listing

Publication Analysis

Top Keywords

netilmicin amikacin
8
netilmicin ceftriaxone
4
ceftriaxone versus
4
versus amikacin
4
amikacin ceftriaxone
4
ceftriaxone treatment
4
treatment infections
4
infections granulocytopenic
4
patients
4
granulocytopenic patients
4

Similar Publications

Background And Aims: Overexpression of MexXY-OprM efflux pump causes resistance to aminoglycosides in . We aimed to investigate the relationship between resistance to aminoglycosides and the MexXY-OprM expression level in clinical isolates without and after treatment with curcumin and/or phenylalanine-arginine-beta-naphthylamide (PAβN) as the efflux pump inhibitors.

Methods: We collected 100 clinical isolates from hospitalized patients.

View Article and Find Full Text PDF
Article Synopsis
  • * A study conducted over two years at Krishna Hospital in India analyzed 82 carbapenem-resistant isolates, revealing a significant prevalence of resistance, particularly among men aged 51-60, predominantly from urine samples in the Intensive Care Unit.
  • * Results showed an alarming 18.7% colistin resistance among CRE isolates, with the most effective alternatives being aminoglycosides like amikacin despite many isolates showing antibiotic resistance.
View Article and Find Full Text PDF

A Cell-Based Screening Assay for rRNA-Targeted Drug Discovery.

ACS Infect Dis

December 2024

Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.

Worldwide, bacterial antibiotic resistance continues to outpace the level of drug development. One way to counteract this threat to society is to identify novel ways to rapidly screen and identify drug candidates in living cells. Developing fluorescent antibiotics that can enter microorganisms and be displaced by potential antimicrobial compounds is an important but challenging endeavor due to the difficulty in entering bacterial cells.

View Article and Find Full Text PDF

Trends in Antimicrobial Resistance of Uropathogens Isolated from Urinary Tract Infections in a Tertiary Care Hospital in Dhaka, Bangladesh.

Antibiotics (Basel)

September 2024

Centre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7ZB, UK.

Article Synopsis
  • Urinary tract infections (UTIs) are common and costly, especially in developing countries, with this study investigating the antimicrobial resistance (AMR) of bacteria causing UTIs in Dhaka, Bangladesh.
  • Among 6549 urine samples, 1001 were positive, showing a higher prevalence in females and revealing that 71.19% of bacterial isolates were multidrug resistant (MDR), especially in children aged 0-10 years.
  • The study found that most uropathogens were resistant to common antibiotics, highlighting the need for regular monitoring of AMR patterns to maintain effective treatment options.
View Article and Find Full Text PDF
Article Synopsis
  • Carbapenems are vital for treating multidrug-resistant infections, but metallo-β-lactamases (MBLs) can inactivate these antibiotics, posing treatment challenges.
  • A study analyzed the presence of MBL genes and their resistance patterns in 228 diarrheal and 142 urinary-tract infection (UTI) isolates, revealing high resistance rates to various antibiotics.
  • Findings showed a notable prevalence of MBL genes, with urgent calls for active surveillance and antibiotic stewardship programs to combat resistance in Bangladesh.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!